'Gut-on-chip' can predict immunotherapy outcomes for melanoma patients
A team of researchers has developed a "gut-on-chip" (a miniature model of the human intestine on a chip-sized device) capable ...
FiercePharma1d
Bristol Myers Squibb comes up short in bid to expand Opdualag in melanoma
Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...
Bristol-Myers' Opdualag fails Phase 3 melanoma study
Bristol-Myers Squibb (NYSE:BMY) said that the Phase 3 RELATIVITY-098 study of its drug Opdualag in the treatment of late-stage melanoma didn't meet its primary endpoint. The drugmaker had been testing ...
modernretina2d
A new technique to estimate melanocytic choroidal tumor thicknesses without B-scan ultrasonography
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
How a mole could turn to BRAIN CANCER after Teddi Mellencamp diagnosis
Real Housewives of Beverly Hills star Teddi Mellencamp, 43, was diagnosed 'multiple' brain tumors that may have been caused ...